Adults who beat Hodgkin lymphoma and made it past the five-year mark still died at nearly twice the rate expected for the general US population, according to a new analysis of more than 20,000 ...

FDA granted Brukinsa Priority Review for mantle cell lymphoma after Phase 3 trial showed a chemo-free regimen reduced disease ...

ADC Therapeutics (NYSE:ADCT) outlined new lymphoma data and plans for further studies of its cancer drug ZYNLONTA, while ...

Lyell Immunopharma (NASDAQ:LYEL) expects pivotal data in mid-2027 for its lead CAR-T cell therapy, ronde-cel, as the company ...

Columvi plus chemo had enhanced survival outcomes vs Rituxan plus chemo in patients with relapsed/refractory diffuse large B-cell lymphoma. Among patients with relapsed/refractory diffuse large B-cell ...

Monjuvi, Revlimid, and Rituxan reduced disease progression risk by 57% in relapsed/refractory follicular lymphoma patients compared to placebo plus Revlimid and Rituxan. The investigational regimen ...

Postoperative Nomogram Predicting the 10-Year Probability of Prostate Cancer Recurrence After Radical Prostatectomy Of 97 assessable patients, 97% responded, and 87% achieved a complete response (CR) ...

Personalized treatment strategies have significantly advanced the management of lung cancer brain metastases, improving patient outcomes. Integration of targeted therapies and immunotherapies offers ...

A small, industry-funded trial found that eating 60 grams of unsalted peanuts daily for 16 weeks improved insulin responsiveness in memory-related brain regions, but not memory or dementia outcomes.

Stage 4 diffuse large B-cell lymphoma (DLBCL) is a rapidly growing lymphoma affecting at least one other organ outside the lymphatic system. Cancer is the unusual growth and spread of cells within the ...